Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 1,713,305 |
|
|||||
| News | - | ||||||
| Day High | 4.03 | Low High |
|||||
| Day Low | 3.78 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Caribou Biosciences Inc | CRBU | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.01 | 0.26% | 3.93 | 16:10:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.90 | 3.78 | 4.03 | 3.87 | 3.92 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,024 | 1,713,305 | $ 3.89 | $ 6,660,795 | - | 3.44 - 8.5899 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:23:20 | 4 | $ 3.94 | USD |
Caribou Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 349.52M | 90.31M | - | 34.48M | -102.07M | -1.13 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Caribou Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRBU Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.37 | 4.3899 | 3.78 | 4.03 | 1,623,739 | -0.44 | -10.07% |
| 1 Month | 5.26 | 5.615 | 3.78 | 4.55 | 1,619,474 | -1.33 | -25.29% |
| 3 Months | 5.45 | 8.33 | 3.78 | 5.80 | 1,643,156 | -1.52 | -27.89% |
| 6 Months | 4.08 | 8.33 | 3.44 | 5.44 | 1,690,208 | -0.15 | -3.68% |
| 1 Year | 4.35 | 8.5899 | 3.44 | 5.68 | 1,921,822 | -0.42 | -9.66% |
| 3 Years | 17.65 | 32.645 | 3.44 | 8.06 | 1,109,882 | -13.72 | -77.73% |
| 5 Years | 17.65 | 32.645 | 3.44 | 8.06 | 1,109,882 | -13.72 | -77.73% |
Caribou Biosciences Description
| Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. |
